These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3818819)

  • 1. The NCI Drug Information System. 5. DIS Biology Module.
    Zehnacker MT; Brennan RH; Milne GW; Miller JA
    J Chem Inf Comput Sci; 1986 Nov; 26(4):186-93. PubMed ID: 3818819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCI Drug Information System. 3. The DIS Chemistry Module.
    Milne GW; Feldman A; Miller JA; Daly GP
    J Chem Inf Comput Sci; 1986 Nov; 26(4):168-79. PubMed ID: 3818817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI Drug Information System. 6. System maintenance.
    Zehnacker MT; Brennan RH; Milne GW; Miller JA; Hammel MJ
    J Chem Inf Comput Sci; 1986 Nov; 26(4):193-7. PubMed ID: 3580042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI Drug Information System. 4. Inventory and Shipping Modules.
    Milne GW; Miller JA; Hoover JR
    J Chem Inf Comput Sci; 1986 Nov; 26(4):179-85. PubMed ID: 3818818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NCI Drug Information System. 2. DIS Pre-Registry.
    Milne GW; Feldman A; Miller JA; Daly GP; Hammel MJ
    J Chem Inf Comput Sci; 1986 Nov; 26(4):159-68. PubMed ID: 3818816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI Drug Information System. 1. System overview.
    Milne GW; Miller JA
    J Chem Inf Comput Sci; 1986 Nov; 26(4):154-9. PubMed ID: 3818815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new NCI screen and its implications for clinical evaluation.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1980; 70():5-20. PubMed ID: 7355249
    [No Abstract]   [Full Text] [Related]  

  • 8. National Cancer Institute Drug Information System 3D database.
    Milne GW; Nicklaus MC; Driscoll JS; Wang S; Zaharevitz D
    J Chem Inf Comput Sci; 1994; 34(5):1219-24. PubMed ID: 7962217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective screening program: current screening and its status.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1981; 76():176-91. PubMed ID: 7232850
    [No Abstract]   [Full Text] [Related]  

  • 11. The National Cancer Institute's Natural Products Antineoplastic Development Program.
    Douros J; Suffness M
    Recent Results Cancer Res; 1980; 70():21-44. PubMed ID: 7355247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM
    Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 14. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM; Macdonald JS; Muggia FM; Henney JE; Devita VT
    Eur J Cancer (1965); 1981 Feb; 17(2):129-42. PubMed ID: 6894902
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 17. The evaluation of cytotoxic drugs.
    Von Hoff DD; Rozencweig M; Muggia FM
    Cancer Treat Rev; 1979 Jun; 6 Suppl():1-8. PubMed ID: 498161
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A.
    Venditti JM; Johnson RK
    Recent Results Cancer Res; 1978; 63():49-57. PubMed ID: 705014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
    Geran RI; Greenberg NH; Macdonald MM; Abbott BJ
    Natl Cancer Inst Monogr; 1977 Mar; (45):151-3. PubMed ID: 927490
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.